Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

grepafloxacin

grepafloxacin
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Raxar TABLET, ORAL 400 mg, 600 mg    
Comments:

ORDERED FORMULATION

THERAPEUTIC INTERCHANGE

NOTES

grepafloxacin (Raxar)

  • 400 mg tablet oral
  • 600 mg tablet oral

levoFLOXacin (Levaquin)

  • 500 mg tablet oral Daily
  • 500 mg tablet oral Daily

As of 2015, grepafloxacin is not marketed in the US
Last updated: Dec. 21, 2017






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved